Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Barnett

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Current Opinion in Neurology|May 17, 2006
The pathology of multiple sclerosis: a paradigm shiftMichael H Barnett, Ian Sutton
Current Opinion in Neurology|April 11, 2012
Neuromyelitis optica: not a multiple sclerosis variantMichael H Barnett, Ian Sutton
Annals of Neurology|March 30, 2004
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesionMichael H Barnett, John W Prineas
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2018
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - YesJustin Y Garber, Michael H Barnett
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 21, 2022
Mechanisms of central brain atrophy in multiple sclerosisSamuel Klistorner, Michael H Barnett, Alexander Klistorner
The Medical Journal of Australia|September 21, 2011
Blurred vision and pain in the eyeMichael H Barnett, Gurjit Chohan, Leo Davies
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2020
Alemtuzumab: Rare serious adverse events of a high-efficacy drugHans-Peter Hartung, Jan Mares, Michael H Barnett
Quantitative Imaging in Medicine and Surgery|March 20, 2020
MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?Yael Barnett, Justin Y Garber, Michael H Barnett
CNS Drugs|March 2, 2017
Effect of Fingolimod on Brain Volume Loss in Patients with Multiple SclerosisNicola De Stefano, Diego G Silva, Michael H Barnett
Plos One|January 18, 2018
White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniquesChenyu Wang, Alexander Klistorner, Linda Ly, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Current Opinion in Neurology|May 17, 2006
The pathology of multiple sclerosis: a paradigm shiftMichael H Barnett, Ian Sutton
Current Opinion in Neurology|April 11, 2012
Neuromyelitis optica: not a multiple sclerosis variantMichael H Barnett, Ian Sutton
Annals of Neurology|March 30, 2004
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesionMichael H Barnett, John W Prineas
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2018
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - YesJustin Y Garber, Michael H Barnett
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 21, 2022
Mechanisms of central brain atrophy in multiple sclerosisSamuel Klistorner, Michael H Barnett, Alexander Klistorner
The Medical Journal of Australia|September 21, 2011
Blurred vision and pain in the eyeMichael H Barnett, Gurjit Chohan, Leo Davies
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2020
Alemtuzumab: Rare serious adverse events of a high-efficacy drugHans-Peter Hartung, Jan Mares, Michael H Barnett
Quantitative Imaging in Medicine and Surgery|March 20, 2020
MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?Yael Barnett, Justin Y Garber, Michael H Barnett
CNS Drugs|March 2, 2017
Effect of Fingolimod on Brain Volume Loss in Patients with Multiple SclerosisNicola De Stefano, Diego G Silva, Michael H Barnett
Plos One|January 18, 2018
White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniquesChenyu Wang, Alexander Klistorner, Linda Ly, et al.
Pageof 12